A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ

A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ

Autism spectrum disorder (ASD) is often associated with debilitating sleep disturbances. While anecdotal evidence suggests the positive effect of cannabinoids, randomized studies are lacking. Here, we report the effects of cannabinoid treatment on the sleep of 150 children and adolescents with ASD,...

Full description

Bibliographic Details
Main Authors: Aviad Schnapp, Moria Harel, Dalit Cayam-Rand, Hanoch Cassuto, Lola Polyansky, Adi Aran
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Biomedicines
Subjects:
autism spectrum disorder
cannabinoids
cannabidiol
tetrahydrocannabinol
clinical trials
randomized controlled
Online Access:https://www.mdpi.com/2227-9059/10/7/1685

Similar Items

Similar Items